WHO WE ARE

NATIONAL PHARMACEUTICAL ASSOCIATION (EGYPT).

EXPERIENCE

NPA is an Egyptian pharmaceutical company that was founded in 2017 by a team of dedicated and experienced medical and pharmaceutical professionals who are committed to providing patients with lifeenhancing and cost-effective treatments.

VALUE

NPA takes it a step further than the treatments currently available, as a small change can make a significant difference, in order to address the needs of specific individuals who are usually overlooked.

DEVELOPMENT

In 2021, NPA implemented some structural and strategic changes to expand its presence in the Greater Cairo and Delta regions. At the same time, NPA began developing a partnership with a major international drug manufacturer to expand its services to Egyptian patients by providing advanced treatments at an affordable price.

About us

NPA is an Egyptian pharmaceutical company that was founded in 2017 by a team of dedicated and experienced medical and pharmaceutical professionals who are committed to providing patients with lifeenhancing and cost-effective treatments.

Vision

To become, in five years, one of the top ten Egyptian pharmaceuticals which provides highquality natural medications with the prospect of expanding into larger regional markets.

Mission

Since its inception, NPA has focused on providing healthcare professionals with products that consist of natural ingredients yet effective treatments so that they can help their patients improve their quality of life at a reasonable cost. Today, NPA is evolving its business model to build a trustable national brand that helps millions of Egyptians maintain their health and beauty with scientifically sound natural products.

Our Products

OUR PRODUCT RANGE IS EXPANDING AND DIVERSIFYING WITH NEW PRODUCTS TO COME. WITH NEW PRODUCTS TO COME.

MANUFACTURING

NPA-Egypt follows an asset-light production model in which it manufactures all its products under contract at other pharmaceutical production facilities. NPA-Egypt is in the process of establishing its own production facility and by 2024 all its products will be manufactured in-house to ensure maximum quality control and to be able to offer more affordable treatments to Egyptian patients.

NPA-Egypt follows an asset-light production model in which it manufactures all its products under contract at other pharmaceutical production facilities. NPA-Egypt is in the process of establishing its own production facility and by 2024 all its products will be manufactured in-house to ensure maximum quality control and to be able to offer more affordable treatments to Egyptian patients.

DISTRBIBUUTITON

WE ARE EXPANDING OUR DISTRIBUTION CHANNELS TO INCLUDE ALL MAJOR DISTRIBUTORS IN EGYPT

Last news